<DOC>
	<DOCNO>NCT03060746</DOCNO>
	<brief_summary>The primary objective obtain stool sample pre-therapy subject already undergo evaluation H. pylori infection upper esophagogastroduodenoscopy ( EGD ) gastric biopsy .</brief_summary>
	<brief_title>Helicobacter Pylori Sample Collection Protocol Pre Therapy Subjects</brief_title>
	<detailed_description>Stools collect test , later date , clinical performance study investigational H. pylorus antigen assay . This study coordinate Sponsor .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<criteria>Adult ≥ 22 year , either gender Subject symptomatic showing sign symptom gastritis Subject evaluation posttherapy follow diagnosis Subject already undergo upper EGD obtain gastric biopsy part routine care H. pylorus diagnose Biopsy obtain antrum and/or corpus test CRM At least two three CRM test perform Subject whose EGD biopsy procedure occur ≤ 7 day prior stool collection Willing able sign IRB approve Informed Consent form project , able provide Informed Consent accordance 21 CFR 50 Subpart B Any subject meet inclusion criterion Subject current severe H. pylorus infection Subject ingest compound may interfere detection H. pylorus e.g . 4 week antibiotic , 2 week Bismuth preparation proton pump inhibitor prior EGD/collection Subject recently test , less 3 month knowledge H. pylori absence Subject test , less one year knowledge H. pylorus presence NOT undergone prescribe treatment Pregnant lactating Inability unwilling perform require study procedure Subject unable unwilling provide inform consent</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>